ATE203397T1 - Verfahren zur herstellung einer festen arzneimitteldosierungsform - Google Patents

Verfahren zur herstellung einer festen arzneimitteldosierungsform

Info

Publication number
ATE203397T1
ATE203397T1 AT96904928T AT96904928T ATE203397T1 AT E203397 T1 ATE203397 T1 AT E203397T1 AT 96904928 T AT96904928 T AT 96904928T AT 96904928 T AT96904928 T AT 96904928T AT E203397 T1 ATE203397 T1 AT E203397T1
Authority
AT
Austria
Prior art keywords
dosage form
producing
mixture
drug dosage
solid drug
Prior art date
Application number
AT96904928T
Other languages
English (en)
Inventor
Andrew William Jordan
Joy Elaine Saunders
Patrick Kearney
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Application granted granted Critical
Publication of ATE203397T1 publication Critical patent/ATE203397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT96904928T 1995-03-02 1996-03-01 Verfahren zur herstellung einer festen arzneimitteldosierungsform ATE203397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504201.6A GB9504201D0 (en) 1995-03-02 1995-03-02 Process for the preparation of a solid pharmaceutical dosage form
PCT/GB1996/000483 WO1996026714A1 (en) 1995-03-02 1996-03-01 Process for the preparation of a solid pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
ATE203397T1 true ATE203397T1 (de) 2001-08-15

Family

ID=10770527

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904928T ATE203397T1 (de) 1995-03-02 1996-03-01 Verfahren zur herstellung einer festen arzneimitteldosierungsform

Country Status (13)

Country Link
US (1) US6423342B1 (de)
EP (1) EP0814770B1 (de)
JP (1) JP2969002B2 (de)
AT (1) ATE203397T1 (de)
AU (1) AU4884596A (de)
DE (1) DE69614096T2 (de)
DK (1) DK0814770T3 (de)
ES (1) ES2160232T3 (de)
GB (1) GB9504201D0 (de)
GR (1) GR3036516T3 (de)
PT (1) PT814770E (de)
WO (1) WO1996026714A1 (de)
ZA (1) ZA961734B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106241A1 (en) * 1995-02-03 2005-05-19 Brewer Francesca M. Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitors
GB9715082D0 (en) * 1997-07-17 1997-09-24 Scherer Ltd R P Treatment of attention deficit hyperactivity disorder and narcolepsy
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
ATE521343T1 (de) * 2004-11-24 2011-09-15 Teva Pharma Im mund zerfallende zusammensetzungen von rasagilin
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
WO2011026080A1 (en) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
AU2017342160A1 (en) 2016-10-13 2019-05-23 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
AU2021212258A1 (en) 2020-01-31 2022-09-29 Nanocopoeia, Llc Amorphous nilotinib microparticles and uses thereof
WO2021222739A1 (en) 2020-04-30 2021-11-04 Nanocopoeia, Llc Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB2111423B (en) * 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) * 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
AUPR666101A0 (en) 2001-07-27 2001-08-16 Inflatable Image Technologies Pty. Limited Inflatable images
DE10144308A1 (de) 2001-09-10 2003-03-27 Haarmann & Reimer Gmbh Verfahren zur Transformation von Amycolatopsis sp. DSM 9991 und DSM 9992

Also Published As

Publication number Publication date
EP0814770B1 (de) 2001-07-25
DE69614096T2 (de) 2002-03-21
ES2160232T3 (es) 2001-11-01
EP0814770A1 (de) 1998-01-07
WO1996026714A1 (en) 1996-09-06
DK0814770T3 (da) 2001-11-05
GB9504201D0 (en) 1995-04-19
JP2969002B2 (ja) 1999-11-02
US6423342B1 (en) 2002-07-23
DE69614096D1 (de) 2001-08-30
ZA961734B (en) 1996-11-01
AU4884596A (en) 1996-09-18
PT814770E (pt) 2001-11-30
JPH10506408A (ja) 1998-06-23
GR3036516T3 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
ATE184480T1 (de) Verfahren zur herstellung von arzneizubereitungen mit verzögerter wirkstoffabgabe
DE69207799D1 (de) Pharmazeutische Zubereitung mit verzögerter Wirkstoffreigabe und Verfahren zur Herstellung derselben
ATE314075T1 (de) Verfahren zur herstellung diphosphonsäure enthaltende feste pharmazeutische darreichungsformen
ATE87469T1 (de) Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
DE69317306D1 (de) Verfahren zur herstellung von pharmazeutische zusammensetzungen mittels ultraschall
ATE203397T1 (de) Verfahren zur herstellung einer festen arzneimitteldosierungsform
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
ES2076412T3 (es) Proceso para la fabricacion de microesferas.
AT382779B (de) Verfahren zur herstellung von festen pharmazeutischen dispersionszusammensetzungen mit rascher wirkstofffreisetzung
ATE137753T1 (de) Codeinsalz einer substituierten carbonsäure, verfahren zu seiner herstellung, seine verwendung und pharmazeutische präparate
ATA863176A (de) Verfahren zur herstellung von neuen ver- bindungen aus einem copolymeren des vinylengly- clos und einer daran chemisch gebundenen biologisch aktiven substanz
ATE77052T1 (de) Verfahren zur herstellung von etofibrat oder aehnliche verbindungen enthaltende mikrogranula mit verzoegerter freisetzung sowie die auf diese weise erhaltenen produkte.
DE69114721D1 (de) Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.
ATE141916T1 (de) Verfahren zur herstellung von 2,3- pyridindicarbonsäure-dialkylestern aus dialkyldichlorosuccinat
KR890006644A (ko) 결정성 β-락탐 수화물
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
DE69513827D1 (de) Verfahren zur herstellung von optisch aktiven alpha-substituierten carbonsäurederivaten
DE59602149D1 (de) Verfahren zur Herstellung von 2-Fluor-isobuttersäure-alkylestern
DE69113840D1 (de) Verfahren zur Herstellung von 2-Halogeno-3-Hydroxy-3-Phenyl-Propionsäureesterverbindungen.
AT341488B (de) Verfahren zur herstellung von neuen pharmazeutisch zulassigen saureadditionssalzen von 1,1,-dialkyl-n-butylaminen
ATA904282A (de) Verfahren zur herstellung von salzen von derivaten von n-oxiranmethan-n,n,n-trialkylammonium
DE3761372D1 (de) Verfahren zur herstellung von zirkoniumcarboxylat.
DE59607239D1 (de) Verfahren zur herstellung von hydroxyhaltigen verbindungen aus ameisensäureestern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification